Keywords
Antiretrovirals
HIV
Maradi
Niger
How to Cite
Abstract
Objective :
The objective of our study was to investigate antiretroviral (ARV) adherence among patients living with HIV (PvVIV).
Methodology :
This was a cross-sectional, analytical, descriptive study that was conducted from June 5 to September 10, 2021. Adherence was assessed using a questionnaire. Patients were considered compliant if they kept their appointments, if they respected their medication schedules and if they missed less than one dose.
Results :
A total of 200 patients were included. Women were strongly represented in the study (72.5%, n=145). The mean age was 43 years with a range of 21 to 72 years. The most prescribed treatment was TDF-3TC-EFV and 11% (n=22) of our sample was taking a traditional treatment. We noted that 64% (n=32) of the study population had missed zero doses. Poor compliance was 35% (n=70) with the main reason being negligence with 47% (n=23), travel 15% (n=7), illness 12% (n=6) and forgetfulness 10% (n=5). An overview of the CD4 lymphocyte count confirmed the efficacy of ARVs in adherent patients.
Conclusion :
In view of this study, there are difficulties in adherence to treatment with antiretrovirals. Therefore, the involvement of health care personnel in the reinforcement of therapeutic education (TE), and the support of the family could contribute to the improvement of adherence in these patients.
References
1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5), 487–497.
2. Hane F. L'observance des traitements dans le cadre du VIH. Un nouvel enjeu pour la prise en charge. Sciences sociales et santé. 2011 ;29 (2) :41-46.
3. Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther 2002;7:185-93
4. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS 2003;17: 169-77.
5. Mouala C, Roux P, okome M, et al. Assessment of compliance with ARV treatment in Africa. Med Trop 2006 ; 66(6) :610-4.
6. ONUSIDA. Statistique mondial sur le VIH.2021.6P
7. Mouala, C., J. Kaba-Mebri, J. B. Wata and J. L. Rey. "[Factors associated with adherence to therapy among HIV-infected patients in Bangui]." Sante. 2006; 16(2): 119-130.
8. Mbopi-Kéou FX, Djomassi LD, Monebenimp F. Etude des facteurs liés à l’observance au traitement antirétroviral chez les patients suivis à l’Unité de Prise En Charge du VIH/SIDA de l’Hôpital de District de Dschang, Cameroun. Pan Afr Med J. 2012; 12(1), P1-11.
9. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. (2006); 43(1), 78-84P.
10. Institut National de la Statistique (INS) et ICF International, 2013. Enquête Démographique et de Santé et à Indicateurs Multiples du Niger 2012.
11. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. International Journal of STD & AIDS 2005; 16 : 38–41.
12. Izizag BB, Situakibanza H, Kiazayawoko F, Nkodila A, Mafuta E, Lukanu P, et al. Déterminants de la non-observance au traitement antirétroviral chez l’adulte à Kinshasa. Pan Afr Med J. 2020; 37:157. doi: 10.11604/pamj.2020.37.157.13261
13. Odili VU, Obieche AO, Amibor KC. Adherence to Antiretroviral Therapy and Its Determinants among HIV-Infected Patients in Nigeria. J. Pharm. Pract. 2017 ; 30(3) : 291-295.
14. Guide de prise en charge des PPVIH. SOLTHIS 2017.
15. Ehlers VJ et Tshisuyi ET. Adherence to antiretroviral treatment by adults in a rural area of Botswana. Curationis. 2015; 38(1) :1-8.
16. Banagi YA, Unnikrishnan B, Ramapuram JT, Kumar N, Mithra P, Kulkarni V, et al. Factors influencing adherence to antiretroviral therapy among people living with HIV in Coastal South India. Journal of the International Association of Providers of AIDS Care (JIAPAC), 2016; 15(6): 529-533.
17. Shanmukhappa SC, Abraham RR, Huilgol P, Godbole R, Anand AK, Prasad R, et al. What influences adherence among HIV patients presenting with first-line antiretroviral therapy failure (ART failure)? A retrospective, cross-sectional study from a private clinic in Nagpur, India. J Family Med Prim Care 2020 ; 9(12) : 6217.
18. Oumar AA, Dao S, Diamoutene A, Coulibaly S, Koumare B, Maiga II, Mariko E. Les Facteurs associés à l’observance du traitement antirétroviral à l’hôpital du Point G. Mali Méd. 2007; 22(1): 18-21.
19. Mengistu Z, Chere A. Adherence to antiretroviral therapy and its associated factors among people living with HIV/AIDS in Addis Ababa, Ethiopia. Ethiop med j. 2012; 50(4): 355-61.
20. Salami AK, Fadeyi A, Ogunmodede JA, Desalu O. Factors influencing adherence to antiretroviral medication in ilorin, nigeria. Journal of the international association of physicians in AIDS care. 2010 ;9(3) : 191-5.
21. Ahmed A, Katlama C, Ghon J, Guiguet M, Costagliola. Evaluation de l’observance au traitement antirétroviral au sein d’une cohorte de 200 patients à Djibouti. " East Mediterr Health J. 2005; 13(6) :1287-97.
22. Obirikorang C, Selleh PK, Sbledu JK, Fofie CO. Predictors of adherence to antiretroviral therapy among HIV/AIDS patients in the upper west region of ghana. ISRN AIDS. 2013; 1-8.
23. Sasaki Y, Kakimoto K, Dube C, Sikazwe I, Moyo C, Syakantu G, et al. Adherence to antiretroviral therapy (art) during the early months of treatment in rural Zambia: influence of demographic characteristics and social surroundings of patients. Ann clin microbiol antimicrob. 2012; 11 :34.
24. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. Barriers to antiretroviral adherence for patients living with hiv infection and AIDS in Botswana. Jaids. 2003 ;34(3) :281-8.
25. Faure N, Diafouka M, Nzounza P, Ekat MH, Mahambou Nsonde D, Levasseur G, et al. Observance thérapeutique des personnes vivant avec le VIH en 2009 au centre de traitement ambulatoire de Brazzaville, Congo. Médecine Tropicale. 2011 ; 71 : 487-49.
26. Oumar AA, Diawara SI, Mbaga MC, Diarra B, Coulibaly SM, Cissoko Y, Bahachimi A, Dembélé JP, Dao S. Observance thérapeutique des antirétroviraux chez les patients suivis au chu du point g : comparaison de deux méthodes de mesure, objective et subjective. Revue malienne de science et de technologie, 2019 ; 21 :95-108
27. Doumbia Y, Oumar AA, Maiga AI, Guindo O, Sanogo M, BA M, Dembélé JP, Dao S. Impact du décalage horaire dans la prise des antirétroviraux sur la charge virale chez les PVVIH suivis à Bamako. Revue Malienne d’Infectiologie et de Microbiologie 2014 ; (4) :1-7.
Metrics
Downloads
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 S Laouali Garba, O Abdoulaye, A Biraima, H Assao Neino, M Harouna Amadou, I Tawaye, N Hama Aghali, K Jataou Bahari, M Doutchi, O Amadou, G Lo, I Issiaka